Laminin inhibition of β-amyloid protein (Aβ) fibrillogenesis and identification of an Aβ binding site localized to the globular domain repeats on the laminin A chain

Journal of Neuroscience Research

Volumn 62, Issue 3, 2000, Pages 451-462

  Castillo, Gerardo M ^a   Lukito, Widia ^b   Peskind, Elaine ^c   Raskind, Murray ^c   Kirschner, Daniel A ^d   Yee, Ann G ^d   Snow, Alan D ^a  

^a ProteoTech Inc   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA Puget Sound Medical Center   (United States)

^d BOSTON COLLEGE   (United States)

Author keywords

Amyloid protein; Amyloid; Blood; Cerebrospinal fluid; Fibrillogenesis; Laminin

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; LAMININ A; PERLECAN; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; DISSOCIATION CONSTANT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS;

AMYLOID; AMYLOID BETA-PROTEIN; BASEMENT MEMBRANE; BINDING SITES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROMETRY; IMMUNOASSAY; LAMININ; MICROSCOPY, ELECTRON; NEGATIVE STAINING; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REPETITIVE SEQUENCES, AMINO ACID; THIAZOLES;

EID: 0034332511     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20001101)62:3<451::AID-JNR15>3.0.CO;2-F     Document Type: Article

References (85)

1. Induction of perlecan gene expression precedes amyloid formation doting experimental murine AA amyloidogenesis
2. Glutamine synthetase-induced enhancement of betaamyloid peptide Aβ (1-40) neurotoxicity accompanied by abrogation of fibril formation and Aβ fragmentation
3. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A
4. Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core
5. Laminin fragments E8 mediates PC12 Cell neurite outgrowth by binding to cell surface β1,4 galactosyltransferase
6. Radioimmunoassay of laminin in serum and its application to cancer patients
7. Laminin blocks the assembly of wild-type Aβ and the Dutch variant peptide into Alzheimer's fibrils
8. A monoclonal antibody against a laminin-heparan sulfate proteoglycan complex perturbs cranial neural crest migration in vivo
9. A new nomenclature for the laminins
10. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells
11. Subunit structure of bovine ESF [extracellular-matrix stabilizing factor(s)]. A chondroitin sulfate proteoglycan with homology tO human I alpha i (inter-alpha-trypsin inhibitors)
12. Novel purification and detailed characterization of perlecan isolated from the Eugelbreth-Holm-Swarm tumor for use in an animal model of Aβ amyloid persistance in brain
13. Laminin is a potent inhibitor of Aβ fibril formation and is an Aβ-binding protein present in human blood and cerebrospinal fluid
14. Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability
15. The sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation
16. Binding of laminin to type IV collagen: A morphological study
17. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation
18. Serum concentrations of laminin in cirrhosis of the liver
19. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
20. Binding of the basement-membrane glycoprotein laminin to glycosaminoglycans. An affinity-chromatography study
21. Laminin 1 attenuates beta-amyloid peptide Aβ (1-40) neurotoxicity of cultured fetal rat cortical neurons
22. Primary structure of the mouse laminin B2 chain and comparison with laminin B1
23. Antibody binding constants from Farr test and other radioimmunoassays. A theoretical and experimental analysis
24. Mapping of domains in human laminin using monoclonal antibodies: Localization of the neurite-promoting site
25. Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein
26. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV
27. Levels of type IV collagen and laminin fragments in serum from patients with progressive systemic sclerosis
28. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
29. Amyloid beta-peptide is produced by cultured cells during normal metabolism
30. Serum laminin P1 fragment concentration in renal diseases
31. Nomenclature of amyloid and amyloidosis
32. Proteoglycans and other basement membrane proteins in amyloidoses
33. Laminin concentrations in serum and cerebrospinal fluid in aging and Alzheimer's disease
34. Formation of a supramolecular complex is involved in the reconstitution of basement membrane components
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Laminin is associated with the 'neurite outgrowth-promoting factors' found in conditioned media
37. Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV) collagen
38. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution
39. Thioflavin T interaction with amyloid beta-sheet structures
40. Laminin is induced in astrocytes of adult brain by injury
41. Laminin and laminin fragments in human blood and cerebrospinal fuid bind Aβ and maintain Aβ solubility
42. Codeposition of basement mambrane components during the induction of murine splenic AA amyloid
43. Characterization of proteolytic fragments of the laminin-nidogen complex and their activity in ligand-binding assays
44. Amyloid plaque core protein in Alzheimer disease and Down syndrome
45. Laminin inhibits Aβ40 fibril formation promoted by apolipoprotein E4 in vitro
46. Laminin inhibits Aβ42 fibril formation m vitro
47. The inhibitory effect of laminin 1 and synthetic peptides deduced from the sequence in the laminin α1 chain on Aβ40 fibril formation in vitro
48. Laminin inhibits both Aβ40 and Aβ42 fibril formation but does not affect Aβ40 or Aβ42-induced cytotoxicity in PC12 cells
49. Laminin and its neurite outgrowth-promoting domain in the brain m Alzheimer's disease and Down's syndrome patients
50. First-order kinetic model of Alzheimer's beta-amyloid fibril extension m vitro
51. Kinetic analysis of amyloid fibril polymerization in vitro
52. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan
53. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins
54. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease
55. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress
56. Microangiopathy, the vascular basement membrane and Alzheimer's disease: A review
57. Vascular basement membrane components and the lesions of Alzheimer's disease: Light and electron microscopic analyses
58. Serum concentrations of laminin P1 in diabetes with advanced nephropathy
59. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier
60. Binding domain for laminin on type IV collagen
61. Functional interactions of neuronal heparan sulphate proteoglycans with laminin
62. Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes
63. Basement membrane glycoprotein laminin binds to heparin
64. The laminin B2 chain has a multidomain structure homologous to the B1 chain
65. Sequence of the cDNA encoding the laminin B1 chain reveals a multidomain protein containing cysteine-rich repeats
66. Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains
67. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
68. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids
69. Serum concentrations of laminin-P1 in diabetes mellitus: Usefullness as an index of diabetic microangiopathy
70. Localization of three distinct heparin-binding domains of laminin by monoclonal antibodies
71. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain
72. Cell and heparin binding in the distal long arm of laminin: Identification of active and cryptic Sites with recombinant and hybrid glycoprotein
73. A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates ceil attachment, migration, and neurite outgrowth
74. An IKLLI-containing peptide derived from the laminin α1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin α3β1 and heparan sulfate proteoglycan
75. Role of laminin in the attachment of PAM 212 (epithelial) cells to basement membrane collagen
76. Structure and biological activity of basement membrane proteins
77. Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease
78. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
79. Levels and molecular size distribution of serum laminin in adult type I diabetic patients with and without microangiopathy
80. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone
81. Beta-amyloid formation by myocytes of leptomeningeal vessels
82. Secretion of laminin alpha 2 chain in cerebrospinal fluid
83. Self-assembly and calcium-binding sites in laminin. A three-arm interaction model
84. Laminin polymerization in vitro. Evidence for a two-step assembly with domain specificity
85. Laminin forms an independent network in basementmembranes